Skip to contentC
Cerenome, Inc.
C
CNSYCerenome, Inc. Q1 2026 · 10-Q
Revenue$1.03M$1.03M−2.9% vs Q1 2025 Net Income-$6.95M-$6.95MN/M vs Q1 2025 EPS Diluted-$1.05-$1.05N/M vs Q1 2025 Operating Income-$7,119,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cerenome, Inc. · CIK 1095981 · Engraved from SEC EDGAR
Free Cash Flowderived-$7,056,000N/M Margins · derivedOperating margin-692.5%−358.6 pt vs Q1 2025
Net margin-675.7%+967.5 pt vs Q1 2025
ended Mar 31, 2026 · filed May 15, 2026 · 45 d after period end